As a GLP-1 medicine, Wegovy carries a boxed warning about a rare thyroid tumor seen in animal studies and is not suitable for anyone with a history of medullary thyroid cancer or MEN 2. Available on prescription
Digestive side effects: Some people experience nausea, constipation, or stomach discomfort, particularly at higher doses
500 kIU ml 1 ), and DPP-IV inhibitor vildagliptin (final concentration
Our study provides scientific insights regarding the use of exogenous antioxidant supplements in cancer patients
The optimal management strategy for such patients, such as the choice of glucose-lowering, antihypertensive and lipid-lowering medications, is an important topic for current and future research
But first, we should explain how the system is supposed to work and how it all got turned upside down